3 recruiting, 2 completed, 2 unknown, 1 not yet recruiting. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Recruiting 3, Completed 2, Unknown 2, Not yet recruiting 1 |
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Long COVID: new trials by email Literature Review of Long COVID trials Research Report on Long COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 30 | 2026-12-30 | 2026-10-16 |
| Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease Kisspeptin 112-121 - Reproductive Disorder, Neurodegeneration | Phase 1 | Recruiting | Stephanie B. Seminara, MD | 40 | 2026-03-10 | 2026-07-13 |
| PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) 11C-PS13 - Long COVID, Post Acute Sequelae of COVID-19 | Phase 1 | Recruiting | National Institute of Mental Health (NIMH) | 60 | 2025-06-18 | 2026-08-18 |
| Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Lumbrokinase - Long Covid, Post-treatment Lyme Disease Syndrome | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 120 | 2024-10-09 | 2026-03-13 |
| Lithium Long COVID Dose-finding Study Lithium - Long COVID | Phase 1 | Completed | State University of New York at Buffalo | 5 | 2023-10-12 | 2024-10-22 |
| Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients umbilical cord mesenchymal stem cell - Long COVID, Post-Acute COVID-19 Syndrome | Phase 1 / Phase 2 | Unknown | Changhai Hospital | 76 | 2023-09-01 | 2024-07-09 |
| Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection Adipose Tissue Harvest, ATCell - Long COVID | Phase 1 | Unknown | American CryoStem Corporation | 20 | 2023-08-01 | 2023-06-09 |
| Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID stellate ganglion block with 0.5% bupivacaine - Post Acute COVID-19 Syndrome, Long COVID | Phase 1 | Completed | Jonathann Kuo, MD | 20 | 2023-01-03 | 2025-03-13 |
Post-Acute COVID-19 Syndrome (8) · Autonomic Nervous System Diseases (1) · COVID-19 (1) · Dysautonomia like disorder (1) · Fatigue Syndrome, Chronic (1) · Inflammation (1) · Lyme Disease (1) · Nerve Degeneration (1) · Post-Lyme Disease Syndrome (1) · Shy-Drager Syndrome (1)
Chronic Disease (8) · Coronaviridae Infections (8) · Coronavirus Infections (8) · Disease Attributes (8) · Infections (8) · Lung Diseases (8) · Nidovirales Infections (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Pneumonia (8) · Pneumonia, Viral (8) · Post-Infectious Disorders (8) · RNA Virus Infections (8) · Respiratory Tract Diseases (8) · Respiratory Tract Infections (8)
11C-PS13 (1) · Bupivacaine (1) · Lipectomy (1) · Lithium (1) · Taurine (1) · lumbrokinase (1)
American CryoStem Corporation (1) · Changhai Hospital (1) · Icahn School of Medicine at Mount Sinai (1) · Jonathann Kuo, MD (1) · National Institute of Mental Health (NIMH) (1) · State University of New York at Buffalo (1) · Stephanie B. Seminara, MD (1) · University of Alberta (1)
United States (5) · China (1)
Anthony Y Dudzinski (1) · David Putrino, PhD, PT (1) · Jonathann Kuo, MD (1) · Lawrence Richer, MD, MSc (1) · Robert B Innis, M.D. (1) · Yuchao Dong, Doctor (1)
R37HD043341 (1)